- outlookindia.com - New Delhi, Jul 8 (PTI) Drug firm Takeda India on Wednesday said it has launched biological drug Vedolizumab under the brand name ''Kynteles'' used for the treatment of adult patients with moderate-to-severely active ulcerative colitis and Crohn''s Disease, at a price of Rs 71,310 per vial in India.
- Sports Illustrated - John Hickey
- CNN - By Katie Hunt, CNN
Many of us instinctively feel the connection between our gut and our brain. That connection and how the range of bacteria residing in our digestive tract -- our microbiome -- might help treat mental illness